Author

Samuel Wagner

Observed names: S Wagner, S. Wagner, Wagner, Samuel

Institution: Bristol-Myers Squibb (United States)

Observed institutions: Pfizer (United States), Princeton University, Bristol-Myers Squibb (United States)

OpenAlex ID: A5112378061

Relationship between Treatment Effects on Progression-Free Survival and Overall Survival in Multiple Myeloma: A Systematic Review and Meta-Analysis of Published Clinical Trial Data

2015 · Shannon Cartier, Bin Zhang, et al. · Oncology Research and Treatment · 35

Patient-reported outcomes with nivolumab in advanced solid cancers

2018 · Scott S. Tykodi, Dirk Schadendorf, et al. · Cancer Treatment Reviews · 23

Evolving Use of Real-World Evidence in the Regulatory Process: a Focus on Immuno-Oncology Treatment and Outcomes

2020 · John C O’Donnell, T Kim Le, et al. · Future Oncology · 21

Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma

2021 · Alind Gupta, Paul Arora, et al. · JCO Clinical Cancer Informatics · 10

Persistence with COX-2 inhibitors in managed care: an analysis of claims data.

2003 · Carolyn Harley, Samuel Wagner · PubMed · 9

A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer

2020 · Joshua A. Roth, Yong Yuan, et al. · Journal of Medical Economics · 7

Eye Care in the Skilled Nursing Facility: A Pilot Study of Prevalence and Treatment Patterns of Glaucoma

2004 · John J. Voytas, Debra Kowalski, et al. · Journal of the American Medical Directors Association · 7

Partitioned Survival Versus State Transition Modeling in Oncology: a Case Study with Nivolumab in Advanced Melanoma

2015 · A Briggs, TM Baker, et al. · Value in Health · 6

Prm126 - a Comparison of Mixture Cure and Standard Parametric Modeling to Estimate Long-term Survival for Small-cell Lung Cancer in Patients Treated With Nivolumab After Progression

2018 · SD Ramsey, M Othus, et al. · Value in Health · 2

PDF

Experience with colorectal cancer: Analysis of patient web forums.

2012 · Kathy Beusterien, Sarah Tsay, et al. · Journal of Clinical Oncology · 1

Puk4 a Comparison of Total Direct Medical Costs Among Patients Receiving Agents Used in the Pharmacologic Management of Overactive Bladder

2005 · HM Harris, Aguila MA Del, et al. · Value in Health · 1

PDF

Pcn219 What Is Worth Knowing at Early Development? Value of Information Analysis Using an Indication-agnostic Web-based Platform: a Case Study

2019 · E. Wu, A. Berardi, et al. · Value in Health

PDF

Meetings and Conferences

2015 · Xiao Dong Xu, Shi Xiu Shao, et al. · Oncology Research and Treatment

PDF

PCN16 Design and Rationale of the Multiple Myeloma Preamble Study: A Prospective, Non-Interventional, Multi-Center Cohort Study

2012 · B. Zhang, D.F. Cella, et al. · Value in Health

PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic Disease

2011 · J. Karweit, S. Nanavati, et al. · Value in Health

T1026 Work Productivity Loss and Activity Impairment in Patients with IBS-Constipation: An Analysis of the National Health and Wellness Survey

2009 · Yaping Xu, Karen Lasch, et al. · Gastroenterology

T1025 Work Productivity Loss and Activity Impairment Associated with Chronic Constipation: An Analysis of the National Health and Wellness Survey

2009 · Yaping Xu, Karen Lasch, et al. · Gastroenterology

Psy38 Impact of Tension Headache on Work Productivity Loss and Activity Impairment

2008 · SC Bolge, H Kannan, et al. · Value in Health

Puk21 Degree of Symptom Bother in Urinary Incontinence

2005 · Aguila MA Del, HM Harris, et al. · Value in Health

Works count: 20

Citation count: 122

H-index: 7

I10-index: 4